CIK 0001430306
- Non-accelerated filer
- Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 261434750
- Phone
- +1 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Director bought 120,000 shares at $0.41 ($48,600)
- 4 Open-market buy Chief Executive Officer bought 98,000 shares at $0.43 ($41,924)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares
- 4 Open-market buy Director bought 25,000 shares
- 4 Open-market buy Director bought 100,000 shares
- 4 Open-market buy Director bought 100,000 shares at $0.79 ($79,180)
- 4/A Open-market buy Director bought 12,500 shares at $2.00 ($25,000)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $2.08 ($41,500)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $2.00 ($4,000)
- 4 Open-market buy Director bought 25,000 shares at $2.00 ($50,000)
- 4 Open-market buy Director bought 50,000 shares at $2.00 ($100,000)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $2.00 ($50,000)
- 4 Open-market buy Director bought 25,000 shares at $2.00 ($50,000)
- 4 Open-market buy DAUGHERTY BRUCE bought 100,000 shares at $2.00 ($200,000)
- 4 Open-market buy Chief Medical Officer bought 20,000 shares at $2.50 ($49,916)
Page 11 of 19 · 376 filings